Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nebulized Lidocaine and Intranasal Midazolam for Reducing Pain/Anxiety of Nasogastric Tube Insertion in Children: A Randomized Clinical Trial

NCT04571879 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT04571879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04571879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nebulized Lidocaine and Intranasal Midazolam for Reducing Pain/Anxiety of Nasogastric Tube Insertion in Children: A Randomized Clinical Trial
Lead sponsor
Hamad Medical Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
August 25, 2021
Completion date
February 28, 2024
Enrollment
48 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

procedural anxiety, procedural pain